Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernd Joachim Krause

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Urologic Oncology|March 11, 2011
Imaging of prostate cancer with PET/CT and radioactively labeled choline derivatesBernd Joachim Krause, Michael Souvatzoglou, Uwe Treiber
Gastrointestinal Cancer Research : GCR|March 5, 2009
The Value of PET Imaging in Patients with Localized Gastroesophageal CancerKatja Ott, Ken Herrmann, Bernd-Joachim Krause, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 4, 2006
Repeat intracoronary beta-brachytherapy using a rhenium-188-filled balloon catheter for recurrent restenosis in patients who failed intracoronary radiation therapyJochen Wöhrle, Bernd Joachim Krause, Thorsten Nusser, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 22, 2009
18F-FDG PET and 18F-FDG PET/CT for assessing response to therapy in esophageal cancerBernd Joachim Krause, Ken Herrmann, Hinrich Wieder, et al.
Nuclear Medicine and Biology|June 5, 2016
Increased choline uptake in macrophages and prostate cancer cells does not allow for differentiation between benign and malignant prostate pathologiesTimo Schwarz, Christof Seidl, Matthias Schiemann, et al.
Journal of Oncology|August 27, 2009
Clinical Applications of FDG PET and PET/CT in Head and Neck CancerAkram Al-Ibraheem, Andreas Buck, Bernd Joachim Krause, et al.
The Lancet. Oncology|July 6, 2010
Radionuclide and hybrid imaging of recurrent prostate cancerAmbros J Beer, Matthias Eiber, Michael Souvatzoglou, et al.
Seminars in Nuclear Medicine|April 4, 2009
Monitoring response to therapeutic interventions in patients with cancerKen Herrmann, Bernd Joachim Krause, Ralph A Bundschuh, et al.
World Journal of Gastroenterology|July 1, 2014
Distinct antifibrogenic effects of erlotinib, sunitinib and sorafenib on rat pancreatic stellate cellsAnne Elsner, Falko Lange, Brit Fitzner, et al.
Plos One|October 27, 2015
Early [18F]FET-PET in Gliomas after Surgical Resection: Comparison with MRI and HistopathologyBenjamin Kläsner, Niels Buchmann, Jens Gempt, et al.
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Urologic Oncology|March 11, 2011
Imaging of prostate cancer with PET/CT and radioactively labeled choline derivatesBernd Joachim Krause, Michael Souvatzoglou, Uwe Treiber
Gastrointestinal Cancer Research : GCR|March 5, 2009
The Value of PET Imaging in Patients with Localized Gastroesophageal CancerKatja Ott, Ken Herrmann, Bernd-Joachim Krause, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 4, 2006
Repeat intracoronary beta-brachytherapy using a rhenium-188-filled balloon catheter for recurrent restenosis in patients who failed intracoronary radiation therapyJochen Wöhrle, Bernd Joachim Krause, Thorsten Nusser, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 22, 2009
18F-FDG PET and 18F-FDG PET/CT for assessing response to therapy in esophageal cancerBernd Joachim Krause, Ken Herrmann, Hinrich Wieder, et al.
Nuclear Medicine and Biology|June 5, 2016
Increased choline uptake in macrophages and prostate cancer cells does not allow for differentiation between benign and malignant prostate pathologiesTimo Schwarz, Christof Seidl, Matthias Schiemann, et al.
Journal of Oncology|August 27, 2009
Clinical Applications of FDG PET and PET/CT in Head and Neck CancerAkram Al-Ibraheem, Andreas Buck, Bernd Joachim Krause, et al.
The Lancet. Oncology|July 6, 2010
Radionuclide and hybrid imaging of recurrent prostate cancerAmbros J Beer, Matthias Eiber, Michael Souvatzoglou, et al.
Seminars in Nuclear Medicine|April 4, 2009
Monitoring response to therapeutic interventions in patients with cancerKen Herrmann, Bernd Joachim Krause, Ralph A Bundschuh, et al.
World Journal of Gastroenterology|July 1, 2014
Distinct antifibrogenic effects of erlotinib, sunitinib and sorafenib on rat pancreatic stellate cellsAnne Elsner, Falko Lange, Brit Fitzner, et al.
Plos One|October 27, 2015
Early [18F]FET-PET in Gliomas after Surgical Resection: Comparison with MRI and HistopathologyBenjamin Kläsner, Niels Buchmann, Jens Gempt, et al.
Pageof 8